BioPharma Drug Discovery

Gilead Sciences committed to Global Elimination of Hepatitis C

 Data Presented at the Global Hepatitis Summit Show that Virally Suppressed Patients from Taiwan with Renal or Hepatic Impairment had High Rates of Vi...

 June 18, 2021 | News

Debiopharm and Ubix Therapeutics o Develop a New Anti-Cancer Modality -

Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company and Ubix Therapeutics (en.ubixtrx.com), a South Korea-based biotech co...

 June 17, 2021 | News

With Serum Institute as a partner, Novavax is poised to launch in India.

The Novavax trials conducted on 29,960 people in the US and Mexico have delivered results that equal the Pfizer NSE -1.09 % and Moderna jabs and do better ...

 June 16, 2021 | News

Harbour BioMed and Dana-Farber to Advance Novel Biotherapies for Cancer Treatment

Harbour BioMed scientists and Dana-Farber researchers will be working together to develop novel oncologic drugs, including bispecific antibodies and CAR-T ...

 June 16, 2021 | News

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy

93% efficacy against predominantly circulating Variants of Concern and Variants of Interest 91% efficacy in high-risk populations 100% efficacy against...

 June 15, 2021 | News

VERAXA Biotech and Quadira Biosciences Enter Partnership on ADC Development

The collaboration will leverage both the advantages of VERAXA's advanced and proprietary position-true click-chemistry-based drug conjugation technology in...

 June 14, 2021 | News

FDA Takes Steps to Increase Availability of COVID-19 Vaccine

The agency is announcing today that it is authorizing for use, under the emergency use authorization (EUA) for the Janssen COVID-19 vaccine, two batches of...

 June 12, 2021 | News

PerkinElmer to help speed drug discovery

Leading academic, research and industry group led by Broad Institute to help speed drug discovery   PerkinElmer, Inc., a global leader committed to ...

 June 11, 2021 | News

FDA’s Decision to Approve New Treatment for Alzheimer’s Disease

This approval is significant in many ways. Aduhelm is the first novel therapy approved for Alzheimer’s disease since 2003. Perhaps more significantly...

 June 09, 2021 | News | By Dr. Patrizia Cavazzoni, Director, FDA Center for Drug Evaluation and Research

Merck’s KEYTRUDA® Given After Surgery Reduced the Risk of Disease Recurrence or Death

First-Time Disease-Free Survival Data to be Presented During Plenary Session at the 2021 ASCO Annual Meeting   Merck’s KEYTRUDA® (pemb...

 June 07, 2021 | News

Samsung Pharm & GemVax present pancreatic cancer immunotherapeutic drug, RIAVAX™

ASCO 2021, which celebrates its 57th anniversary this year, runs from June 4th to June 8th and will be held virtually due to COVID-19. Some ...

 June 07, 2021 | News

China NMPA Approves MicuRx's Contezolid for Treatment of Drug-Resistant Bacterial Infection

By leveraging the proprietary technology platform built for drug discovery and screening, MicuRx R&D team discovered the next-generation oxazolidinone ...

 June 04, 2021 | News

TLC and Strides partner to launch Black Fungus Drug in India

TLC (Nasdaq: TLC, TWO: 4152), a clinical‐stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, and...

 June 02, 2021 | News

Mycovia Pharmaceuticals Submits New Drug Application to the U.S. FDA

Also known as chronic yeast infection, RVVC is a debilitating infectious condition defined as three or more episodes per year. Although RVVC affects nearly...

 June 02, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close